SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
28-Dec-23 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 28-Dec-23 | Purchase | 857 | $13.35 | $11,441.20 | < 1% 533.15K to 534.01K | |
28-Dec-23 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 26-Dec-23 | Purchase | 48,693 | $13.15 | $640,313.00 | 10% 484.46K to 533.15K | |
11-Dec-23 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 07-Dec-23 | Purchase | 101,050 | $12.85 | $1,298,470.00 | 5% 2.12M to 2.22M | |
20-Nov-23 10:00 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 17-Nov-23 | Purchase | 300 | $12.50 | $3,750.00 | < 1% 2.12M to 2.12M | |
16-Nov-23 5:09 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 14-Nov-23 | Purchase | 50,170 | $12.50 | $627,125.00 | 2% 2.07M to 2.12M | |
14-Nov-23 10:00 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 13-Nov-23 | Purchase | 15,570 | $12.39 | $192,875.00 | < 1% 2.05M to 2.07M | |
14-Nov-23 10:00 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 10-Nov-23 | Purchase | 38,062 | $12.32 | $469,008.00 | 2% 2.01M to 2.05M | |
13-Nov-23 10:00 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 09-Nov-23 | Purchase | 9,975 | $12.19 | $121,618.00 | < 1% 2.0M to 2.01M | |
13-Nov-23 10:00 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 08-Nov-23 | Purchase | 13,823 | $12.13 | $167,701.00 | < 1% 1.99M to 2.0M | |
09-Aug-23 4:06 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 08-Aug-23 | Purchase | 87,057 | $12.00 | $1,044,330.00 | 5% 1.9M to 1.99M | |
09-Aug-23 4:06 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 07-Aug-23 | Purchase | 134,493 | $12.00 | $1,614,410.00 | 8% 1.77M to 1.9M | |
22-Mar-23 4:06 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 21-Mar-23 | Purchase | 160,590 | $11.52 | $1,850,000.00 | 10% 1.61M to 1.77M | |
01-Feb-23 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 31-Jan-23 | Purchase | 2,232 | $11.40 | $25,444.40 | < 1% 1.61M to 1.61M | |
01-Feb-23 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 30-Jan-23 | Purchase | 24,708 | $11.36 | $280,624.00 | 2% 1.58M to 1.61M | |
31-Jan-23 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 27-Jan-23 | Purchase | 21,875 | $11.40 | $249,298.00 | 1% 1.56M to 1.58M | |
04-Jan-23 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 03-Jan-23 | Purchase | 30,632 | $11.33 | $347,159.00 | 2% 1.53M to 1.56M | |
03-Jan-23 4:16 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 30-Dec-22 | Purchase | 41,300 | $11.33 | $468,040.00 | 3% 1.49M to 1.53M | |
03-Jan-23 4:16 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 29-Dec-22 | Purchase | 218,636 | $10.55 | $2,306,680.00 | 17% 1.27M to 1.49M | |
16-Apr-21 10:00 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 14-Apr-21 | Market Purchase | 47,300 | $6.63 | $313,736.00 | 4% 1.22M to 1.27M | (4%) |
15-Apr-21 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 13-Apr-21 | Market Purchase | 9,874 | $6.26 | $61,779.60 | < 1% 1.21M to 1.22M | 2% |
14-Apr-21 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 12-Apr-21 | Market Purchase | 23,629 | $6.06 | $143,194.00 | 2% 1.19M to 1.21M | 5% |
27-Nov-20 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 24-Nov-20 | Market Purchase | 69,088 | $3.65 | $252,171.00 | 6% 1.12M to 1.19M | 74% |
16-Nov-20 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 12-Nov-20 | Market Purchase | 56,490 | $3.65 | $206,188.00 | 5% 1.06M to 1.12M | 74% |
17-Aug-20 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 13-Aug-20 | Market Purchase | 609 | $3.50 | $2,131.50 | < 1% 1.06M to 1.06M | 82% |
13-Aug-20 4:06 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 12-Aug-20 | Market Purchase Duplicate | 2,000 | $3.49 | $6,986.00 | < 1% 1.06M to 1.06M | 82% |
13-Aug-20 4:06 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 11-Aug-20 | Market Purchase | 14,030 | $3.45 | $48,437.20 | 1% 1.05M to 1.06M | 84% |
24-Jul-20 6:59 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 22-Jul-20 | Market Purchase | 177,274 | $3.11 | $552,086.00 | 20% 869.36K to 1.05M | 105% |
22-Apr-20 2:27 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 21-Apr-20 | Market Purchase | 1,424 | $3.25 | $4,628.00 | < 1% 867.93K to 869.35K | 96% |
22-Apr-20 2:27 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 20-Apr-20 | Market Purchase | 2,325 | $3.25 | $7,556.25 | < 1% 865.61K to 867.93K | 96% |
08-Apr-20 5:40 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 07-Apr-20 | Market Purchase Duplicate | 5,899 | $3.03 | $17,884.60 | < 1% 859.71K to 865.61K | 110% |
07-Apr-20 7:23 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 06-Apr-20 | Market Purchase | 6,043 | $3.00 | $18,107.80 | < 1% 853.66K to 859.71K | 113% |
07-Apr-20 7:23 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 03-Apr-20 | Market Purchase | 10,750 | $2.60 | $27,924.20 | 1% 842.91K to 853.66K | 145% |